Advertisement
Screener

FITLIFE BRANDS, INC. (FTLF) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

FITLIFE BRANDS, INC. Comprehensive Income

FITLIFE BRANDS, INC. (FTLF) reported Comprehensive Income of $1.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-13

  • FITLIFE BRANDS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $1.94M, a 4.14% increase year-over-year.
  • FITLIFE BRANDS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $1.73M, a 15.73% decline year-over-year.
  • FITLIFE BRANDS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$2.71M, a 247.33% decline year-over-year.
  • FITLIFE BRANDS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $847.00K, a 60.81% decline year-over-year.
  • FITLIFE BRANDS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $8.61M, a 72.14% increase from fiscal 2023.
  • FITLIFE BRANDS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $5.00M, a 12.98% increase from fiscal 2022.
  • FITLIFE BRANDS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $4.43M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed
2026-06-30$1.94M
10-Q · filed 2026-08-13
$3.66M
10-Q · filed 2026-08-13
$955.00K
derived: sum of 3 quarters · filed 2026-08-13
$1.80M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$1.73M
10-Q · filed 2026-05-14
-$980.00K
derived: sum of 2 quarters · filed 2026-05-14
-$133.00K
derived: sum of 3 quarters · filed 2026-05-14
$1.73M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$2.71M
derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-14
-$1.86M
derived: sum of 2 quarters · filed 2026-05-14
$0.00
derived: sum of 3 quarters · filed 2026-08-13
$2.05M
10-Q · filed 2026-05-14
$6.43M
10-K · filed 2026-03-31
2025-09-30$847.00K
10-Q · filed 2025-11-13
$2.71M
derived: sum of 2 quarters · filed 2026-08-13
$4.75M
10-Q · filed 2025-11-13
$6.59M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$1.86M
10-Q · filed 2026-08-13
$3.90M
10-Q · filed 2026-08-13
$5.74M
derived: sum of 3 quarters · filed 2026-08-13
$7.90M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$2.05M
10-Q · filed 2025-05-15
$3.88M
derived: sum of 2 quarters · filed 2026-03-31
$6.04M
derived: sum of 3 quarters · filed 2026-03-31
$8.42M
derived: sum of 4 quarters · filed 2026-03-31
2024-12-31$1.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$4.00M
derived: sum of 2 quarters · filed 2026-03-31
$6.38M
derived: sum of 3 quarters · filed 2026-03-31
$8.61M
10-K · filed 2026-03-31
2024-09-30$2.16M
10-Q · filed 2025-11-13
$4.54M
derived: sum of 2 quarters · filed 2025-11-13
$6.78M
10-Q · filed 2025-11-13
$8.02M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$2.38M
10-Q · filed 2025-08-14
$4.62M
10-Q · filed 2025-08-14
$5.85M
derived: sum of 3 quarters · filed 2025-08-14
$7.23M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$2.24M
10-Q · filed 2025-05-15
$3.48M
derived: sum of 2 quarters · filed 2025-05-15
$4.85M
derived: sum of 3 quarters · filed 2025-05-15
$7.07M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$2.62M
derived: sum of 2 quarters · filed 2025-03-27
$4.83M
derived: sum of 3 quarters · filed 2025-03-27
$5.00M
10-K · filed 2025-03-27
2023-09-30$1.38M
10-Q · filed 2024-11-14
$3.59M
derived: sum of 2 quarters · filed 2024-11-14
$3.77M
10-Q · filed 2024-11-14
$4.22M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$2.21M
10-Q · filed 2024-08-14
$2.39M
10-Q · filed 2024-08-14
$2.84M
derived: sum of 3 quarters · filed 2024-08-14
$4.06M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$156.00K
10-Q · filed 2024-05-14
$629.00K
derived: sum of 2 quarters · filed 2024-05-14
$1.85M
derived: sum of 3 quarters · filed 2024-05-14
$3.29M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$473.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$1.69M
derived: sum of 2 quarters · filed 2024-03-29
$3.14M
derived: sum of 3 quarters · filed 2024-03-29
$4.43M
10-K · filed 2024-03-29
2022-09-30$1.22M
10-Q · filed 2023-11-13
$2.67M
derived: sum of 2 quarters · filed 2023-11-13
$3.96M
10-Q · filed 2023-11-13
2022-06-30$1.45M
10-Q · filed 2023-08-14
$2.74M
10-Q · filed 2023-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87